The CHROME Study, a Real-world Experience of Single- and Multiple-Dose Oritavancin for Treatment of Gram-Positive Infections

Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin

(2019) Samira Dahesh et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Long-Acting Lipoglycopeptides: “Lineless Antibiotics” for Serious Infections in Persons Who Use Drugs

(2019) Taylor Morrisette et al.   Open Forum Infectious Diseases

Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies

(2018) G. Ralph Corey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Real-world Patient Registry for Oritavancin Demonstrates Efficacy and Safety Consistent With the Phase 3 SOLO Program

(2018) Mark Redell et al.   Open Forum Infectious Diseases

Treatment of chronic osteomyelitis with multi-dose oritavancin: a case series and literature review

(2018) Daniel B. Chastain et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Multiple-Dose Oritavancin Evaluation in a Retrospective Cohort of Patients with Complicated Infections

(2017) Lucas T Schulz et al.   PHARMACOTHERAPY

Successful Treatment of Methicillin Susceptible Staphylococcus aureus Osteomyelitis with Oritavancin

(2017) Dino J. Delaportas et al.   PHARMACOTHERAPY

Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus

(2016) G. Ralph Corey et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection

(2015) Michael W. Dunne et al.   CLINICAL INFECTIOUS DISEASES

Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study

(2014) G. Ralph Corey et al.   CLINICAL INFECTIOUS DISEASES

Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections

(2014) G. Ralph Corey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection

(2014) Helen W. Boucher et al.   NEW ENGLAND JOURNAL OF MEDICINE